What is the recommended treatment for a patient with a positive Chlamydia (Chlamydia trachomatis) result and an Intrauterine Device (IUD) in place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Chlamydia Infection with IUD in Place

For patients with a positive Chlamydia trachomatis result and an IUD in place, the recommended treatment is azithromycin 1 g orally in a single dose OR doxycycline 100 mg orally twice daily for 7 days, and the IUD can remain in place during and after treatment. 1, 2

First-Line Treatment Options

• Azithromycin 1 g orally in a single dose 1 • Doxycycline 100 mg orally twice daily for 7 days 1

Both treatments are equally efficacious with cure rates of 97-98% 1. The choice between these two regimens should consider:

• Azithromycin advantages: Single-dose therapy, directly observed treatment possible, better for patients with questionable compliance 1 • Doxycycline advantages: Lower cost, extensive history of use and safety 1

Alternative Treatment Regimens

If first-line treatments cannot be used, consider:

• Erythromycin base 500 mg orally four times a day for 7 days 1 • Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 1 • Ofloxacin 300 mg orally twice a day for 7 days 1 • Levofloxacin 500 mg orally once daily for 7 days 1

Note that erythromycin may cause gastrointestinal side effects that can reduce compliance 1.

Management of the IUD

• The IUD can safely remain in place during and after treatment for chlamydial infection 2 • There is no need to remove the IUD for treatment of uncomplicated chlamydial infection 2 • The risk of PID with an IUD in situ is less than 1% 2

Additional Management Considerations

• Partners should be notified, examined, and treated for chlamydia to prevent reinfection 1 • Patients should abstain from sexual intercourse until:

  • They and their partners complete treatment 1
  • 7 days after single-dose therapy or until completion of a 7-day regimen 1

• Test-of-cure is not routinely recommended after completing treatment with doxycycline or azithromycin 1 • Consider retesting females 3-4 weeks after treatment if using erythromycin regimens 1

Risk Factors for Treatment Failure or Reinfection

• Age ≤24 years 3 • Recent new sexual partner 3 • Multiple sexual partners 3 • Partner with multiple partners 3 • Untreated partners 3

Important Clinical Considerations

• Chlamydial infection can lead to serious sequelae in women including PID, ectopic pregnancy, and infertility 1 • Some women with apparently uncomplicated cervical infection may already have subclinical upper reproductive tract infection 1 • Treatment of cervical infection is believed to reduce the likelihood of these sequelae 1 • Medications for chlamydial infections should ideally be dispensed on-site, with the first dose directly observed to maximize compliance 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.